2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow agalsidase alfa: new trials by email Literature Review of agalsidase alfa trials Research Report on agalsidase alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease Lucerastat, Enzyme replacement therapy (ERT) - Fabry Disease | Phase 1 | Completed | Idorsia Pharmaceuticals Ltd. | 14 | 2015-02-01 | 2018-07-10 |
| An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease Replagal agalsidase alfa, Replagal - Fabry Disease | Phase 1 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 3 | 2003-10-01 | 2011-08-17 |
Fabry Disease (2) · Peripheral Nervous System Diseases (1) · Stroke (1)
Idorsia Pharmaceuticals Ltd. (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1)
Germany (1) · United States (1)